Pharmacokinetics and saturable renal tubular secretion of zidovudine in rats
β Scribed by Bela A. Patel; Chung K. Chu; F. Douglas Boudinot
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 671 KB
- Volume
- 78
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
β¦ Synopsis
The purpose of this study was to assess the effects of dose on the pharmacokinetics of zidovudine (3'-azido-3'-deoxythymidine; AZT) in rats. Zidovudine (AZT) was administered intravenously at doses of 10, 50, 100, and 250 mgikg. Plasma and urine AZT concentrations were determined by HPLC. Plasma AZT concentrations declined rapidly with a terminal half-life ranging from 0.76 h at a dose of 10 mg/kg to 1.58 h at 250 mgikg. Total clearance (CL,) was similar at the doses of 10 and 50 mg/kg, with values of 2.80 and 2.73 Uh/kg, respectively. However, there was a trend toward nonlinearity at the dose of 100 mg/kg (CL, = 2.13 Uhikg) and a significant decrease in CL, (1.22 Uh/kg) at the dose of 250 mgikg. Nonrenal clearance remained unaffected by dose with a mean value of 0.98 Uhikg. Renal clearance (CL,) was similar at the doses of 10 and 50 mg/kg, with values of 1.89 and 1.37 Uh/kg, respectively. However, significant decreases in CL, were observed at the
π SIMILAR VOLUMES
From the determination of the Michaehs-Menten kinetic parameters (V, and Km) of renal tubular secretion of D-( -)p-n-propylmandelic acid (V) and D-( -)-p-isopropylmandelic acid (VI) in rats, it is shown that these compounds involve the same renal tubular carrier for their secretion but the affinity
Pharmacokinetic parameters of oltipraz were compared after intravenous and oral administration at a dose of 30 mg/kg to control rats and rats with U-ARF. After intravenous administration to rats with U-ARF, the AUC was significantly greater (1100 versus 1730 mg Γ min/mL) than that in control rats, a